Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, May 17, 2022
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
[ Tue, May 17th 2022
] - WOPRAI
Mon, May 16, 2022
[ Mon, May 16th 2022
] - WOPRAI
Sean Lee Maintained (CASI) at Strong Buy with Decreased Target to $30 on, May 16th, 2022
Sean Lee of HC Wainwright & Co., Maintained "CASI Pharmaceuticals, Inc." (CASI) at Strong Buy with Decreased Target from $40 to $30 on, May 16th, 2022.
Sean, nor any peers, have made any analyst calls on CASI in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30